ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Improving Quality of Life for Allergic and Nonallergic Rhinitis Patients

by Fromer, Margot • December 1, 2007

  • Tweet
  • Email
Print-Friendly Version

WASHINGTON, DC—Rhinitis—inflammation of the nasal mucosa—has two main types: allergic (IgE-mediated) and nonallergic; together, they affect more than 50 million Americans. Both types diminish quality of life, result in about 20 million physician visits each year, and cost billions of dollars. Robert M. Naclerio, MD, Professor of Surgery and Section Chief of Otolaryngology Head and Neck Surgery at the University of Chicago, and two of his colleagues at that institution, Fuad M. Baroody, MD, and Jayant M. Pinto, MD, discussed new developments in the management of rhinitis.

You Might Also Like

  • SCIT Effective for Asthma, Allergic Rhinitis
  • Dissonance Between Patients’ and Physicians’ Perceptions of Allergic Rhinitis and Effects of Medications
  • AAO-HNS14: Nonallergic Rhinitis Difficult to Define
  • Rhinophototherapy May Offer Promise to Allergic Rhinitis Patients
Explore This Issue
December 2007

Seasonal Allergic Rhinitis

Assessing the severity of seasonal allergic rhinitis (SAR), contrary to what one would intuit, is related more to quality-of-life factors than to physiological ones, said Dr. Naclerio. For example, sufferers performed worse on cognitive tests and exhibited sometimes dangerous daytime sleepiness because SAR affects their ability to sleep at night.

One also might think that avoidance of allergens would alleviate most of the symptoms, but that too is wrong, he added. “Although the studies we have are poor, we do know, for instance, that reducing dust mites, by current recommendations, has little effect on the clinical impact of dust mite-induced rhinitis. In fact, not many environmental factors appear to have much of an effect—except stopping smoking and reducing exposure to secondhand smoke.” Both alter dendritic cell function, increase respiratory symptoms, and decrease the effect of inhaled corticosteroids when they are used.

Avoidance issues are especially pertinent for children whose allergic parents are often unduly worried about their children developing allergies. SAR can be delayed with avoidance to allergens, but it will show up eventually. “What you buy in the short run, you lose in the long run,” Dr. Naclerio said. “Smoking is the one thing parents can control and they should stop it. A number of studies support this recommendation.”

Dr. Pinto told the audience that people with SAR and asthma have a reduced ability to condition air. “Because these individuals have inflammation in the nose, we hypothesized that treatment with an intranasal steroid would reduce nasal inflammation and decrease nasal conditioning capacity.”

Therefore, Dr. Pinto and his colleagues performed a randomized, double-blind, placebo-controlled study on 20 people with asthma to compare the effect of treatment with intranasal budesonide (Rhinocort) on nasal conditioning for two weeks. The drug reduced inflammation in the nonsmokers, but had no effect in the smokers. In the subgroup of nonsmokers who had a significant reduction in inflammation, the nasal conditioning was also reduced, as predicted.

Pages: 1 2 3 | Single Page

Filed Under: Allergy, Rhinology Issue: December 2007

You Might Also Like:

  • SCIT Effective for Asthma, Allergic Rhinitis
  • Dissonance Between Patients’ and Physicians’ Perceptions of Allergic Rhinitis and Effects of Medications
  • AAO-HNS14: Nonallergic Rhinitis Difficult to Define
  • Rhinophototherapy May Offer Promise to Allergic Rhinitis Patients

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Weaning Patients Off of PPIs
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Vertigo in the Elderly: What Does It Mean?
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Podcasts Becoming More Popular Method of Education for Otolaryngologists
    • How to Embrace Optimism in the Midst of the COVID-19 Pandemic
    • Tips on How to Approach Conversations with Patients about the COVID-19 Vaccine
    • Steps You Should Take to Protect Your Voice and Hearing During Telemedicine Sessions
    • Routine Postoperative Adjunct Treatments Unnecessary for Idiopathic Cerebrospinal Fluid Leaks

Polls

Have you spoken with your patients about receiving the COVID-19 vaccine?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.